Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Scientists have unveiled a new way to capture ultra-sharp optical images without lenses or painstaking alignment. The ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

The Cancer Biomarkers Market is poised for robust expansion driven by escalating industry demand, accelerated technological ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing ...

Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

The field of immunotherapy has revolutionized the treatment of advanced non-small cell lung cancer (NSCLC), particularly ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...